FDA approves New Therapy Aimed at a New Target in Esophageal Cancer at the GE Junction
The Food and Drug Administration (FDA) has approved Zolbetuximab (Vyloy) as a first-line treatment for patients with advanced HER2* [...]
Study finds Regimen that doesn’t include Radiation is Better than current Standard
A German study finds a 30% reduction in the risk of death among Esophageal Adenocarcinoma patients who were treated [...]
FDA Advisory Panel votes to limit some EC patients’ access to immunotherapy
In 2021, Esophageal Cancer patients and advocates celebrated the Food and Drug Administration’s approval of immunotherapies for patients with [...]
Powerful Tool to Catch Esophageal Cancer Before It Starts
A newly released study of the benefits of the EsoGuard® Esophageal DNA test says it is a powerful screening [...]
Five-Year Data on Immunotherapy for Advanced Esophageal Cancer Shows Tripling of Survival Rate
At the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, long-term data from [...]
New Discovery: Inherited Gene Mutation linked to Esophageal Adenocarcinoma
A breakthrough by researchers at Case Western Reserve has led to the discovery of an Inherited Gene Mutation linked to [...]
ECAN Launches New, Animated Guide for Patients at Risk for Esophageal Cancer
With animations that illustrate how to prevent, detect, treat, and cure Esophageal Cancer, ECAN, in partnership with the International Society [...]
New, Free Clinical Trials Matching
ECAN is proud to launch a new, personalized service to match Esophageal Cancer patients with the best Clinical Trial [...]
Beta Blockers to Improve Immunotherapy Response
Less than a third of Esophageal Cancer Patients Respond to Immunotherapy. Could a Medication Commonly Used to Treat Anxiety [...]
Study finds Drug Increases Appetite, Weight Gain for Cancer Patients
Low doses of an inexpensive, well-tolerated drug were found to increase the appetite, weight gain, and quality of life for [...]